Webinars » Revolutionizing Therapeutics and Genomic Research with Cutting-Edge mRNA Technologies

Revolutionizing Therapeutics and Genomic Research with Cutting-Edge mRNA Technologies

Delve into exciting new technologies pushing the boundaries in research and advancing the development of novel therapeutics. Through a series of engaging presentations by experts in the fields of synthetic peptide technologies, genome editing, and drug development, our speakers will dive into the latest advances and trends in neoantigen peptide discovery for personalized cancer immunotherapy, the promising potential of mRNA-based tools for gene editing, and the innovative world of self-amplifying RNAs as a cutting-edge modality, shaping the next generation of RNA vaccines.

Webinar Details

  • Title: Session 1: Applications and Challenges of Neoantigen Peptides in Personalized Cancer Vaccines
  • Speaker: Dr. Shan She, Senior Global Product Manager, GenScript Biotech Corporation
  • Date: Nov 20, 2024
  • Time: 09:00 (New York Time)
  • This webinar introduces the fundamentals of neoantigen peptide discovery and its importance in personalized cancer immunotherapy. Dr. Shan She, Senior Global Product Manager at GenScript will discuss advances and current trends in neoantigen peptide applications, emphasizing their potential to improve the specificity and effectiveness of cancer vaccines.
    • Registration
  • Title: Session 2: Advanced mRNA and LNP Strategies for CRISPR Delivery
  • Speaker: Dr. Shambhavi Shubham, Senior Scientist, GenScript USA Inc
  • Date: Dec 4, 2024
  • Time: 10:00 (New York Time)
  • In this webinar, Dr. Shambhavi Shubham, field application scientist at GenScript will share how the company harnesses advanced formulations of CRISPR enzymes like Cas9 and Cas12, and Prime editing to achieve powerful gene editing. To further elevate performance, GenScript leverages advanced strategies, including customizing CRISPR mRNAs with tissue-specific UTRs, optimizing IVT conditions to reduce dsRNA, and using codon optimization and circular RNA forms. Moreover, to meet precise delivery needs, GenScript technology leverages antibody-decorated or SORT LNPs.
    • Registration
  • Title: Session 3: Self-Amplifying RNA in Vaccines and Beyond
  • Speaker: Dr. Mark Shulewitz, Field Application Scientist, GenScript USA Inc
  • Date: Dec 18, 2024
  • Time: 10:00 (New York Time)
  • This webinar will delve into the innovative world of self-amplifying RNAs as a cutting-edge RNA modality. Throughout the session, we will explore what self-amplifying RNAs are, how they differ from conventional RNA and their potential impact on shaping the next generation of RNA vaccines and other therapeutic applications.
    • Registration

Speaker-related Webinars

Latest Webinars

Find More CRISPR Categories »

Revolutionizing Therapeutics and Genomic Research with Cutting-Edge mRNA Technologies

Revolutionizing Therapeutics and Genomic Research with Cutting-Edge mRNA Technologies

Self-Amplifying RNA in Vaccines and Beyond

Self-Amplifying RNA in Vaccines and Beyond

Boost CRISPR Editing Efficiency: Optimizing sgRNA and HDR Template Design | GenScript

Boost CRISPR Editing Efficiency: Optimizing sgRNA and HDR Template Design | GenScript